Works matching DE "ANTINEOPLASTIC agents"
Results: 5000
THE PROTECTIVE ROLE OF INTESTINAL MICROBIOTA IN COLORECTAL CANCER TREATMENT: A SCOPING REVIEW.
- Published in:
- Texto & Contexto Enfermagem, 2024, v. 33, p. 1, doi. 10.1590/1980-265X-TCE-2024-0109en
- By:
- Publication type:
- Article
QUIMIO EM CASA: APPLICATION FOR FAMILY MEMBERS OF CHILDREN AND ADOLESCENTS USING ORAL ANTINEOPLASTIC AGENTS.
- Published in:
- Texto & Contexto Enfermagem, 2022, v. 31, p. 1, doi. 10.1590/1980-265X-TCE-2021-0414en
- By:
- Publication type:
- Article
ERRATUM: PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW.
- Published in:
- Texto & Contexto Enfermagem, 2020, v. 29, n. 1, p. 1, doi. 10.1590/1980-265X-TCE-2018-0312er
- Publication type:
- Article
TELENURSING FOR THE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: A RANDOMIZED CLINICAL TRIAL.
- Published in:
- Texto & Contexto Enfermagem, 2019, v. 28, p. 1, doi. 10.1590/1980-265X-TCE-2018-0404
- By:
- Publication type:
- Article
PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW.
- Published in:
- Texto & Contexto Enfermagem, 2019, v. 28, p. 1, doi. 10.1590/1980-265X-TCE-2018-0312
- By:
- Publication type:
- Article
ERRATUM: PATIENT SAFETY IN THE ADMINISTRATION OF ANTINEOPLASTIC CHEMOTHERAPY AND OF IMMUNOTHERAPICS FOR ONCOLOGICAL TREATMENT: SCOPING REVIEW.
- Published in:
- Texto & Contexto Enfermagem, 2019, v. 28, p. 1, doi. 10.1590/1980-265X-TCE-2018-0312er
- Publication type:
- Article
Advanced DLBCL: As Systemic Therapy Improves, the Need for RT Diminishes.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1085
- By:
- Publication type:
- Article
Improving Outcomes in Advanced DLBCL: Systemic Approaches and Radiotherapy.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1074
- By:
- Publication type:
- Article
Chemotherapy for Low-Grade Gliomas: Lessons and Questions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1043
- By:
- Publication type:
- Article
Chemotherapy for Treatment of Grade II Gliomas.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1036
- By:
- Publication type:
- Article
Prognostic and Predictive Markers for the New Immunotherapies.
- Published in:
- Oncology (08909091), 2014, p. 1
- By:
- Publication type:
- Article
CTLA-4 Antibodies: New Directions, New Combinations.
- Published in:
- Oncology (08909091), 2014, p. 1
- By:
- Publication type:
- Article
Pancreatic Metastases From Renal Cell Carcinoma Treated With Stereotactic Body Radiation Therapy.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 1008, doi. 10.46883/onc.2014.2811.1008
- By:
- Publication type:
- Article
Expanding Androgen- and Androgen Receptor Signaling-Directed Therapies for Castration- Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 8, p. 693
- By:
- Publication type:
- Article
Small Steps That Lead to a Giant Leap for Prostate Cancer Patients.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 8, p. 652
- By:
- Publication type:
- Article
Metastatic Adrenocortical Carcinoma With a Prolonged Response to Mitotane.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 624
- By:
- Publication type:
- Article
Updates on the Management of Breast Cancer Brain Metastases.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 572
- By:
- Publication type:
- Article
Management of Breast Cancer Brain Metastases Is Moving Forward, but New Options Are Still Needed.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 585
- By:
- Publication type:
- Article
Esophagogastric Junction and Gastric Adenocarcinoma: Neoadjuvant and Adjuvant Therapy, and Future Directions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 505
- By:
- Publication type:
- Article
Salvage Chemotherapy for Refractory Germ Cell Tumors.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 498
- By:
- Publication type:
- Article
Cardiovascular Toxicity of Newer Chemotherapeutic Agents: The Heart of the Matter.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 493
- By:
- Publication type:
- Article
It's Time to Have 'The Talk': Cost Communication and Patient-Centered Care.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 479
- By:
- Publication type:
- Article
Cardiovascular Toxicity of Biologic Agents for Cancer Therapy.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 482
- By:
- Publication type:
- Article
The Challenge of Managing Increasingly Complex Cancer Toxicity.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 454
- By:
- Publication type:
- Article
Colorectal Cancer and Molecular Targeted Agents: Progress--With Caveats.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Colorectal Cancer: How Emerging Molecular Understanding Affects Treatment Decisions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 110
- By:
- Publication type:
- Article
Overview and Management of Cardiac and Pulmonary Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib: Page 2 of 2.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Expanding Options for Pancreatic Cancer... So Where Do We Go From Here?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 1, p. 5
- By:
- Publication type:
- Article
Overview and Management of Cardiac and Pulmonary Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Managing Adverse Events of Multiple Myeloma and Anti--Multiple Myeloma Treatment: A Perspective on Carfilzomib.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib: Page 2 of 2.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
The Place of Transplantation in Mantle Cell Lymphoma.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
The Place of Transplantation in Mantle Cell Lymphoma: Page 2 of 2.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Peripheral T-Cell Lymphoma: Time for a T-Cell-Centric Standard of Care.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 9, p. 885
- By:
- Publication type:
- Article
Peripheral T-Cell Lymphoma: New Therapeutic Strategies.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 9, p. 878
- By:
- Publication type:
- Article
FDA Approves Afatinib for Advanced Lung Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 8, p. 813
- Publication type:
- Article
Is IL-2 Still Indicated for Melanoma and RCC? What a Question to Ask!
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 695
- By:
- Publication type:
- Article
Ruxolitinib for Myelofibrosis: From 'Palliation' to Prolongation of Survival.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 717
- By:
- Publication type:
- Article
Improving Disease Burden in Myelofibrosis: Changing the Natural History of the Disease.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 715
- By:
- Publication type:
- Article
Clarifying the Use of Ruxolitinib in Patients With Myelofibrosis.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 706
- By:
- Publication type:
- Article
Weighing the Evidence for Immune Therapy and Targeted Therapy in Renal Cancer and Melanoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 691
- By:
- Publication type:
- Article
High-Dose Interleukin-2: Is It Still Indicated for Melanoma and RCC in an Era of Targeted Therapies?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 680
- By:
- Publication type:
- Article
Postmenopausal Hormone ReceptorPositive Advanced Breast Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 6, p. 1
- By:
- Publication type:
- Article
Consultations IN Ethics.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 4, p. 348
- By:
- Publication type:
- Article
Oligodendrogliomas: Questions Answered, Answers Questioned.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 4, p. 326
- By:
- Publication type:
- Article
Treatment of Anaplastic Oligodendrogliomas: Should Resources Be Used to Codify the Old or to Create the New?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 4, p. 322
- By:
- Publication type:
- Article
Treatment Recommendations for Anaplastic Oligodendrogliomas That Are Codeleted.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 4, p. 315
- By:
- Publication type:
- Article
Recurrent Epithelial Ovarian Cancer: An Update on Treatment.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 4, p. 288
- By:
- Publication type:
- Article
Supportive Care of the Patient With Advanced Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 183
- By:
- Publication type:
- Article